Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'

被引：0
|
作者：
Homer, N. [1 ]
Grewal, D. S. [1 ]
Mirza, R. G. [1 ]
Lyon, A. T. [1 ]
Gill, M. K. [1 ]
机构：
[1] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
EYE | 2015年 / 29卷 / 12期
关键词：
D O I：
10.1038/eye.2015.191
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1630 / 1631
页数：3
相关论文
共 50 条
  • [11] Two year results of intravitreal aflibercept injections for neovascular age-related macular degeneration using a treat and extend regimen
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Hosogi, Mika
    Doi, Shinichiro
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [12] A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
    Kikushima, Wataru
    Sakurada, Yoichi
    Fukuda, Yoshiko
    Matsubara, Mio
    Kotoda, Yumi
    Sugiyama, Atsushi
    Kashiwagi, Kenji
    PHARMACEUTICALS, 2023, 16 (04)
  • [13] Reactivation of stable neovascular age-related macular degeneration following treat-and-extend regimen discontinuation
    Artiaga, Jose Carlo M.
    Wong, Shiao Wei
    Menon, Deepthy
    Kumar, Swetha
    Dhoble, Pankaja
    Thottarath, Sridevi
    Nicholson, Luke
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2025, 53 (01): : 76 - 83
  • [14] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Mohamed Kamel Soliman
    Nicolas Tuli
    Thomas K. Lee
    William A. Britton
    Raman Tuli
    International Journal of Retina and Vitreous, 7
  • [15] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Soliman, Mohamed Kamel
    Tuli, Nicolas
    Lee, Thomas K.
    Britton, William A.
    Tuli, Raman
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [16] Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration
    Hidetaka Matsumoto
    Takashi Hiroe
    Masahiro Morimoto
    Kensuke Mimura
    Arisa Ito
    Hideo Akiyama
    Japanese Journal of Ophthalmology, 2018, 62 : 144 - 150
  • [17] Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hiroe, Takashi
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2018, 62 (02) : 144 - 150
  • [18] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Alaa Din Abdin
    Shady Suffo
    Fatima Asi
    Achim Langenbucher
    Berthold Seitz
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1671 - 1677
  • [19] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Abdin, Alaa Din
    Suffo, Shady
    Asi, Fatima
    Langenbucher, Achim
    Seitz, Berthold
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (08) : 1671 - 1677
  • [20] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Aki Kato
    Tsutomu Yasukawa
    Iichiro Sugita
    Munenori Yoshida
    Miho Nozaki
    Yoshio Hirano
    Junko Kondo
    Tomohiro Abe
    Kimiko Sugita
    Takahide Okita
    Hiroshi Morita
    Noriaki Takase
    Yuichiro Ogura
    Advances in Therapy, 2022, 39 : 1403 - 1416
12345